Factors hindering the degradation of pharmaceuticals from human urine in an iron-activated persulfate system

•Hydrolyzed urine notably inhibited pharmaceutical removal in the mFe-PS system.•Phosphate, (bi)carbonate and pH hinder pharmaceutical removal in the mFe-PS system.•Phosphate and carbonate radicals decreased pharmaceutical removal efficiencies.•Phosphate radicals preferentially attack the benzene ri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of environmental sciences (China) 2024-01, Vol.135, p.130-148
Hauptverfasser: Xie, Yiruiwen, Guan, Dao, Deng, Yangfan, Sato, Yugo, Luo, Yu, Chen, Guanghao
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 148
container_issue
container_start_page 130
container_title Journal of environmental sciences (China)
container_volume 135
creator Xie, Yiruiwen
Guan, Dao
Deng, Yangfan
Sato, Yugo
Luo, Yu
Chen, Guanghao
description •Hydrolyzed urine notably inhibited pharmaceutical removal in the mFe-PS system.•Phosphate, (bi)carbonate and pH hinder pharmaceutical removal in the mFe-PS system.•Phosphate and carbonate radicals decreased pharmaceutical removal efficiencies.•Phosphate radicals preferentially attack the benzene ring of pharmaceuticals.•Carbonate radicals react with pharmaceuticals through hydroxylation preferentially. This study investigated the degradation of clofibric acid (CFA), bezafibrate (BZF), and sulfamethoxazole (SMX) in synthetic human urine using a novel mesoporous iron powder-activated persulfate system (mFe-PS system), and identified the factors limiting their degradation in synthetic human urine. A kinetic model was established to expose the radical production in various reaction conditions, and experiments were conducted to verify the modeling results. In the phosphate-containing mFe-PS system, the 120 min removal efficiency of CFA decreased from 95.1% to 76.6% as the phosphate concentration increased from 0.32 to 6.45 mmol/L, but recovered to 90.5% when phosphate concentration increased to 16.10 mmol/L. Meanwhile, the increased concentration of phosphate from 0.32 to 16.10 mmol/L reduced the BZF degradation efficacy from 91.5% to 79.0%, whereas SMX removal improved from 37.3% to 62.9%. The mFe-PS system containing (bi)carbonate, from 4.20 to 166.70 mmol/L, reduced CFA and BZF removal efficiencies from 100% to 76.8% and 80.4%, respectively, and SMX from 83.5% to 56.7% within a 120-min reaction time. In addition, alkaline conditions (pH ≥ 8.0) inhibited CFA and BZF degradations, while nonacidic pH (pH ≥ 7.0) remarkably inhibited SMX degradation. Results of the kinetic model indicated the formation of phosphate (H2PO4·/HPO4·−) and/or carbonate radicals (CO3·−) could limit pharmaceutical removal. The transformation products (TPs) of the pharmaceuticals revealed more incompletely oxidized TPs occurred in the phosphate- and (bi)carbonate-containing mFe-PS systems, and indicated that H2PO4·/HPO4·− mainly degraded pharmaceuticals via a benzene ring-opening reaction while CO3·− preferentially oxidized pharmaceuticals via a hydroxylation reaction. [Display omitted]
doi_str_mv 10.1016/j.jes.2022.12.022
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2871655353</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1001074222006362</els_id><sourcerecordid>2834202234</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-251b315a5662620446fd1127c82d14bdef346aa655ed6488d67636b68e239be13</originalsourceid><addsrcrecordid>eNqNkTtPwzAUhS0EEqXwA9g8siT4FSeICVW8pEosMFuufdM6SuJgO5X673FVZsR0znC-I917ELqlpKSEyvuu7CCWjDBWUlZmOUML2tRNUXNGzrMnhBakFuwSXcXYEUJERaoF6l-0ST5EvHOjheDGLU47wBa2QVudnB-xb_G002HQBubkjO4jboMf8G4e9IjnzAB2I87eBT8Wuc_tdQKLJwhx7tvscTzEBMM1umgzDje_ukRfL8-fq7di_fH6vnpaF4ZLngpW0Q2nla6kZJIRIWRrKWW1aZilYmOh5UJqLasKrBRNY2UtudzIBhh_2ADlS3R36p2C_54hJjW4aKDv9Qh-joo1Nc00r_g_olwcv8pFjtJT1AQfY4BWTcENOhwUJeo4gupUHkEd44oydaSW6PHEQD537yCoaByMBqwLYJKy3v1B_wC4iI-3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2834202234</pqid></control><display><type>article</type><title>Factors hindering the degradation of pharmaceuticals from human urine in an iron-activated persulfate system</title><source>Elsevier ScienceDirect Journals</source><source>Alma/SFX Local Collection</source><creator>Xie, Yiruiwen ; Guan, Dao ; Deng, Yangfan ; Sato, Yugo ; Luo, Yu ; Chen, Guanghao</creator><creatorcontrib>Xie, Yiruiwen ; Guan, Dao ; Deng, Yangfan ; Sato, Yugo ; Luo, Yu ; Chen, Guanghao</creatorcontrib><description>•Hydrolyzed urine notably inhibited pharmaceutical removal in the mFe-PS system.•Phosphate, (bi)carbonate and pH hinder pharmaceutical removal in the mFe-PS system.•Phosphate and carbonate radicals decreased pharmaceutical removal efficiencies.•Phosphate radicals preferentially attack the benzene ring of pharmaceuticals.•Carbonate radicals react with pharmaceuticals through hydroxylation preferentially. This study investigated the degradation of clofibric acid (CFA), bezafibrate (BZF), and sulfamethoxazole (SMX) in synthetic human urine using a novel mesoporous iron powder-activated persulfate system (mFe-PS system), and identified the factors limiting their degradation in synthetic human urine. A kinetic model was established to expose the radical production in various reaction conditions, and experiments were conducted to verify the modeling results. In the phosphate-containing mFe-PS system, the 120 min removal efficiency of CFA decreased from 95.1% to 76.6% as the phosphate concentration increased from 0.32 to 6.45 mmol/L, but recovered to 90.5% when phosphate concentration increased to 16.10 mmol/L. Meanwhile, the increased concentration of phosphate from 0.32 to 16.10 mmol/L reduced the BZF degradation efficacy from 91.5% to 79.0%, whereas SMX removal improved from 37.3% to 62.9%. The mFe-PS system containing (bi)carbonate, from 4.20 to 166.70 mmol/L, reduced CFA and BZF removal efficiencies from 100% to 76.8% and 80.4%, respectively, and SMX from 83.5% to 56.7% within a 120-min reaction time. In addition, alkaline conditions (pH ≥ 8.0) inhibited CFA and BZF degradations, while nonacidic pH (pH ≥ 7.0) remarkably inhibited SMX degradation. Results of the kinetic model indicated the formation of phosphate (H2PO4·/HPO4·−) and/or carbonate radicals (CO3·−) could limit pharmaceutical removal. The transformation products (TPs) of the pharmaceuticals revealed more incompletely oxidized TPs occurred in the phosphate- and (bi)carbonate-containing mFe-PS systems, and indicated that H2PO4·/HPO4·− mainly degraded pharmaceuticals via a benzene ring-opening reaction while CO3·− preferentially oxidized pharmaceuticals via a hydroxylation reaction. [Display omitted]</description><identifier>ISSN: 1001-0742</identifier><identifier>EISSN: 1878-7320</identifier><identifier>DOI: 10.1016/j.jes.2022.12.022</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>benzene ; Carbonate radicals ; carbonates ; clofibric acid ; Human urine ; humans ; hydroxylation ; Iron-activated persulfate system ; kinetics ; oxidation ; Pharmaceutical degradation ; Phosphate radicals ; phosphates ; porous media ; sulfamethoxazole ; Transformation products ; urine</subject><ispartof>Journal of environmental sciences (China), 2024-01, Vol.135, p.130-148</ispartof><rights>2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c363t-251b315a5662620446fd1127c82d14bdef346aa655ed6488d67636b68e239be13</citedby><cites>FETCH-LOGICAL-c363t-251b315a5662620446fd1127c82d14bdef346aa655ed6488d67636b68e239be13</cites><orcidid>0000-0002-5443-2699 ; 0000-0002-3896-0176 ; 0000-0002-1479-9808</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jes.2022.12.022$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids></links><search><creatorcontrib>Xie, Yiruiwen</creatorcontrib><creatorcontrib>Guan, Dao</creatorcontrib><creatorcontrib>Deng, Yangfan</creatorcontrib><creatorcontrib>Sato, Yugo</creatorcontrib><creatorcontrib>Luo, Yu</creatorcontrib><creatorcontrib>Chen, Guanghao</creatorcontrib><title>Factors hindering the degradation of pharmaceuticals from human urine in an iron-activated persulfate system</title><title>Journal of environmental sciences (China)</title><description>•Hydrolyzed urine notably inhibited pharmaceutical removal in the mFe-PS system.•Phosphate, (bi)carbonate and pH hinder pharmaceutical removal in the mFe-PS system.•Phosphate and carbonate radicals decreased pharmaceutical removal efficiencies.•Phosphate radicals preferentially attack the benzene ring of pharmaceuticals.•Carbonate radicals react with pharmaceuticals through hydroxylation preferentially. This study investigated the degradation of clofibric acid (CFA), bezafibrate (BZF), and sulfamethoxazole (SMX) in synthetic human urine using a novel mesoporous iron powder-activated persulfate system (mFe-PS system), and identified the factors limiting their degradation in synthetic human urine. A kinetic model was established to expose the radical production in various reaction conditions, and experiments were conducted to verify the modeling results. In the phosphate-containing mFe-PS system, the 120 min removal efficiency of CFA decreased from 95.1% to 76.6% as the phosphate concentration increased from 0.32 to 6.45 mmol/L, but recovered to 90.5% when phosphate concentration increased to 16.10 mmol/L. Meanwhile, the increased concentration of phosphate from 0.32 to 16.10 mmol/L reduced the BZF degradation efficacy from 91.5% to 79.0%, whereas SMX removal improved from 37.3% to 62.9%. The mFe-PS system containing (bi)carbonate, from 4.20 to 166.70 mmol/L, reduced CFA and BZF removal efficiencies from 100% to 76.8% and 80.4%, respectively, and SMX from 83.5% to 56.7% within a 120-min reaction time. In addition, alkaline conditions (pH ≥ 8.0) inhibited CFA and BZF degradations, while nonacidic pH (pH ≥ 7.0) remarkably inhibited SMX degradation. Results of the kinetic model indicated the formation of phosphate (H2PO4·/HPO4·−) and/or carbonate radicals (CO3·−) could limit pharmaceutical removal. The transformation products (TPs) of the pharmaceuticals revealed more incompletely oxidized TPs occurred in the phosphate- and (bi)carbonate-containing mFe-PS systems, and indicated that H2PO4·/HPO4·− mainly degraded pharmaceuticals via a benzene ring-opening reaction while CO3·− preferentially oxidized pharmaceuticals via a hydroxylation reaction. [Display omitted]</description><subject>benzene</subject><subject>Carbonate radicals</subject><subject>carbonates</subject><subject>clofibric acid</subject><subject>Human urine</subject><subject>humans</subject><subject>hydroxylation</subject><subject>Iron-activated persulfate system</subject><subject>kinetics</subject><subject>oxidation</subject><subject>Pharmaceutical degradation</subject><subject>Phosphate radicals</subject><subject>phosphates</subject><subject>porous media</subject><subject>sulfamethoxazole</subject><subject>Transformation products</subject><subject>urine</subject><issn>1001-0742</issn><issn>1878-7320</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqNkTtPwzAUhS0EEqXwA9g8siT4FSeICVW8pEosMFuufdM6SuJgO5X673FVZsR0znC-I917ELqlpKSEyvuu7CCWjDBWUlZmOUML2tRNUXNGzrMnhBakFuwSXcXYEUJERaoF6l-0ST5EvHOjheDGLU47wBa2QVudnB-xb_G002HQBubkjO4jboMf8G4e9IjnzAB2I87eBT8Wuc_tdQKLJwhx7tvscTzEBMM1umgzDje_ukRfL8-fq7di_fH6vnpaF4ZLngpW0Q2nla6kZJIRIWRrKWW1aZilYmOh5UJqLasKrBRNY2UtudzIBhh_2ADlS3R36p2C_54hJjW4aKDv9Qh-joo1Nc00r_g_olwcv8pFjtJT1AQfY4BWTcENOhwUJeo4gupUHkEd44oydaSW6PHEQD537yCoaByMBqwLYJKy3v1B_wC4iI-3</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Xie, Yiruiwen</creator><creator>Guan, Dao</creator><creator>Deng, Yangfan</creator><creator>Sato, Yugo</creator><creator>Luo, Yu</creator><creator>Chen, Guanghao</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7S9</scope><scope>L.6</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5443-2699</orcidid><orcidid>https://orcid.org/0000-0002-3896-0176</orcidid><orcidid>https://orcid.org/0000-0002-1479-9808</orcidid></search><sort><creationdate>202401</creationdate><title>Factors hindering the degradation of pharmaceuticals from human urine in an iron-activated persulfate system</title><author>Xie, Yiruiwen ; Guan, Dao ; Deng, Yangfan ; Sato, Yugo ; Luo, Yu ; Chen, Guanghao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-251b315a5662620446fd1127c82d14bdef346aa655ed6488d67636b68e239be13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>benzene</topic><topic>Carbonate radicals</topic><topic>carbonates</topic><topic>clofibric acid</topic><topic>Human urine</topic><topic>humans</topic><topic>hydroxylation</topic><topic>Iron-activated persulfate system</topic><topic>kinetics</topic><topic>oxidation</topic><topic>Pharmaceutical degradation</topic><topic>Phosphate radicals</topic><topic>phosphates</topic><topic>porous media</topic><topic>sulfamethoxazole</topic><topic>Transformation products</topic><topic>urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xie, Yiruiwen</creatorcontrib><creatorcontrib>Guan, Dao</creatorcontrib><creatorcontrib>Deng, Yangfan</creatorcontrib><creatorcontrib>Sato, Yugo</creatorcontrib><creatorcontrib>Luo, Yu</creatorcontrib><creatorcontrib>Chen, Guanghao</creatorcontrib><collection>CrossRef</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of environmental sciences (China)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xie, Yiruiwen</au><au>Guan, Dao</au><au>Deng, Yangfan</au><au>Sato, Yugo</au><au>Luo, Yu</au><au>Chen, Guanghao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors hindering the degradation of pharmaceuticals from human urine in an iron-activated persulfate system</atitle><jtitle>Journal of environmental sciences (China)</jtitle><date>2024-01</date><risdate>2024</risdate><volume>135</volume><spage>130</spage><epage>148</epage><pages>130-148</pages><issn>1001-0742</issn><eissn>1878-7320</eissn><abstract>•Hydrolyzed urine notably inhibited pharmaceutical removal in the mFe-PS system.•Phosphate, (bi)carbonate and pH hinder pharmaceutical removal in the mFe-PS system.•Phosphate and carbonate radicals decreased pharmaceutical removal efficiencies.•Phosphate radicals preferentially attack the benzene ring of pharmaceuticals.•Carbonate radicals react with pharmaceuticals through hydroxylation preferentially. This study investigated the degradation of clofibric acid (CFA), bezafibrate (BZF), and sulfamethoxazole (SMX) in synthetic human urine using a novel mesoporous iron powder-activated persulfate system (mFe-PS system), and identified the factors limiting their degradation in synthetic human urine. A kinetic model was established to expose the radical production in various reaction conditions, and experiments were conducted to verify the modeling results. In the phosphate-containing mFe-PS system, the 120 min removal efficiency of CFA decreased from 95.1% to 76.6% as the phosphate concentration increased from 0.32 to 6.45 mmol/L, but recovered to 90.5% when phosphate concentration increased to 16.10 mmol/L. Meanwhile, the increased concentration of phosphate from 0.32 to 16.10 mmol/L reduced the BZF degradation efficacy from 91.5% to 79.0%, whereas SMX removal improved from 37.3% to 62.9%. The mFe-PS system containing (bi)carbonate, from 4.20 to 166.70 mmol/L, reduced CFA and BZF removal efficiencies from 100% to 76.8% and 80.4%, respectively, and SMX from 83.5% to 56.7% within a 120-min reaction time. In addition, alkaline conditions (pH ≥ 8.0) inhibited CFA and BZF degradations, while nonacidic pH (pH ≥ 7.0) remarkably inhibited SMX degradation. Results of the kinetic model indicated the formation of phosphate (H2PO4·/HPO4·−) and/or carbonate radicals (CO3·−) could limit pharmaceutical removal. The transformation products (TPs) of the pharmaceuticals revealed more incompletely oxidized TPs occurred in the phosphate- and (bi)carbonate-containing mFe-PS systems, and indicated that H2PO4·/HPO4·− mainly degraded pharmaceuticals via a benzene ring-opening reaction while CO3·− preferentially oxidized pharmaceuticals via a hydroxylation reaction. [Display omitted]</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.jes.2022.12.022</doi><tpages>19</tpages><orcidid>https://orcid.org/0000-0002-5443-2699</orcidid><orcidid>https://orcid.org/0000-0002-3896-0176</orcidid><orcidid>https://orcid.org/0000-0002-1479-9808</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1001-0742
ispartof Journal of environmental sciences (China), 2024-01, Vol.135, p.130-148
issn 1001-0742
1878-7320
language eng
recordid cdi_proquest_miscellaneous_2871655353
source Elsevier ScienceDirect Journals; Alma/SFX Local Collection
subjects benzene
Carbonate radicals
carbonates
clofibric acid
Human urine
humans
hydroxylation
Iron-activated persulfate system
kinetics
oxidation
Pharmaceutical degradation
Phosphate radicals
phosphates
porous media
sulfamethoxazole
Transformation products
urine
title Factors hindering the degradation of pharmaceuticals from human urine in an iron-activated persulfate system
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T02%3A59%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20hindering%20the%20degradation%20of%20pharmaceuticals%20from%20human%20urine%20in%20an%20iron-activated%20persulfate%20system&rft.jtitle=Journal%20of%20environmental%20sciences%20(China)&rft.au=Xie,%20Yiruiwen&rft.date=2024-01&rft.volume=135&rft.spage=130&rft.epage=148&rft.pages=130-148&rft.issn=1001-0742&rft.eissn=1878-7320&rft_id=info:doi/10.1016/j.jes.2022.12.022&rft_dat=%3Cproquest_cross%3E2834202234%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2834202234&rft_id=info:pmid/&rft_els_id=S1001074222006362&rfr_iscdi=true